Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Human Wild-type PAI-1 (WT-15) (ID# 7619)
2'-F-RNA
Human Wild-type PAI-1
Protein
177 pM (reported value)
Rounds 1-5: BSA Binding Buffer E(20 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl2, and 0.1% BSA)
Rounds 6-7: CHAPS Binding Buffer E( 20 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)
Rounds8-9: CHAPS Binding Buffer F(20 mM HEPES (pH 7.4), 150 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)
Rounds 6-7: CHAPS Binding Buffer E( 20 mM HEPES (pH 7.4), 50 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)
Rounds8-9: CHAPS Binding Buffer F(20 mM HEPES (pH 7.4), 150 mM NaCl, 2 mM CaCl2, and 0.05% CHAPS)
37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-rGprGprGprAprGprGprApfCprGprApfUprGpfCprGprGprApfUpfCprAprApfCpfUpfCprApfCpfCprGpfUprAprGprGpfUpfCpfUprAprGpfUprGprAprGprAprApfCpfUpfUpfCprAprAprGp fUpfCpfUprApfCpfUpfCprAprGprApfCprGprApfCpfUpfCprGpfCpfUprGprAprGprGprApfUpfCpfCp-3'
76
24575.68
755600
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Blake et al. "Antimetastatic Potential of PAI-1-Specific RNA Aptamers." Oligonucleotides, 19(2009): 117-128.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.